Breadcrumb Home 2016 IMPAACT Annual Meeting Tuberculosis Scientific Committee Presentations 2016 IMPAACT Annual Meeting Tuberculosis Scientific Committee Presentations TB Scientific Committee Monday, June 13, 2016 2016 Updates from the Tuberculosis Scientific Committee and PHOENIx, a Trial of MDR-TB Prevention in Households Anneke Hesseling and Amita Gupta TB Trials in Adults and Opportunities for Children and Pregnant Women for MDR-TB, DS-TB Kelly Dooley Emerging Data on Key Second Line TB drugs in Children: Levofloxacin and Amikacin (Contact IMPAACT Operations Center) Tony Garcia-Prats Designing a MDR-TB Injectable Sparing Regimen in Children: Research Priorities, Design Considerations and Discussion Anneke Hesseling and Simon Schaaf Application of Pharmacometrics to TB PK Studies in Children and Pregnant Women – Case Based Experiences Rada Savic TB Biomarkers and Applications for TB Prevention Trials (Contact IMPAACT Operations Center) Thomas Scriba Utility of IGRAs in HIV-exposed and Infected Children in the IMPAACT P1041 TB Prevention Trial (Contact IMPAACT Operations Center) Lisa Cranmer
